Tenecteplase thrombolytic therapy for acute ischaemic stroke in China: a real-world, multicentre, retrospective, controlled study
Thrombolysis with TNK is not associated with an increased risk of sICH, and may result in better early neurological improvement and 90-day functional outcomes compared with alteplase in patients with AIS.
Authors
- Xin Cheng (ORCID: https://orcid.org/0000-0001-7816-0547)
- Kun Fang (ORCID: https://orcid.org/0009-0003-2943-147X)
- Lan Hong (ORCID: https://orcid.org/0000-0002-4002-4627)
- Qiang Dong (ORCID: https://orcid.org/0000-0002-3874-0130)
- Yangu Liu (ORCID: https://orcid.org/0000-0003-0648-1696)
- Zhanwen He (ORCID: https://orcid.org/0000-0001-8408-6398)
- Anqi Zhang (ORCID: https://orcid.org/0000-0003-0360-5024)
- Dan Li (ORCID: https://orcid.org/0000-0001-5978-5381)
- Yannan Fang (ORCID: https://orcid.org/0000-0002-5800-9484)
- Guozhi Lu (ORCID: https://orcid.org/0000-0002-9669-7193)
- Xiaoyu Zhou (ORCID: https://orcid.org/0000-0002-3947-1788)
- Wu Guang
- Rongbo Qu
Institutions
- Binzhou Medical University (CN)
- Shandong University of Aeronautics (CN)
- Henan University (CN)
- Fudan University (CN)
- Shanghai Tenth People's Hospital (CN)
- Huashan Hospital (CN)
Publication Details
- Journal
- Stroke and Vascular Neurology
- Published
- 2024-11-13
- DOI
- https://doi.org/10.1136/svn-2024-003381
- Citations
- 5
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 1.93
Funders
- Shanghai Municipal Health Commission
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality